FDA NDC Directory · JSON-LD · Markdown
NDC 0406-8956 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE
| Generic name | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate |
|---|---|
| Labeler / Manufacturer | SpecGx LLC |
| Marketing category | Abbreviated NDA (generic) · App ANDA211547 |
| Dosage form / route | CAPSULE, EXTENDED RELEASE · ORAL |
| Active ingredients | AMPHETAMINE ASPARTATE MONOHYDRATE (7.5 mg/1) AMPHETAMINE SULFATE (7.5 mg/1) DEXTROAMPHETAMINE SACCHARATE (7.5 mg/1) DEXTROAMPHETAMINE SULFATE (7.5 mg/1) |
| Marketing started | 20190422 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).